Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Avoid Boosting the Vaccine Premium on Delta Air Lines Stock

Airline stocks are rising on Covid-19 vaccine hopes. But with a return to normal years away, investors are paying a premium for DAL stock.

GoodRx Will Be OK, Despite Fears About Amazon Pharmacy

GoodRx will be OK despite fears about Amazon Pharmacy. GoodRx stock looks like reasonable value, given its profitable business model and FCF.

Be Wary as iBio Seeks a Place in the Vaccine Game

IBIO stock remains volatile as the company continues its focus on a breakthrough product to combat the coronavirus pandemic.

Avoid Tilray Stock While Shares Are Fueled by Political FOMO

It's fine to anticipate positive developments in the broader cannabis market, but loading up on Tilray stock isn't the best move now.

7 Cheap Stocks Under $20 To Buy That Span Industries

Cheap stocks can be a great investment if you do your due diligence. Click here for seven such stocks already done for you.

After Governmental Boosts, Lyft Is Getting Back to Even

Lyft used the pandemic to cut costs and should be profitable in 2021. However, investors are already paying a big multiple for Lyft stock.

After Surviving the Pandemic, What’s Next for Darden Restaurants?

With small restaurants shut by the pandemic, Olive Garden is becoming the height of fine dining. But how long will the vacuum last?

Airline Stocks: As Americans Return to the Skies, Make This Trade

From an investment standpoint, the COVID-19 pandemic had made the airline sector one to avoid. But now, it may be one to embrace. Here's why.

Is the Triple in Ripple the Best We Can Expect from This Crypto?

Cryptocurrencies offer tremendous upside potential though the volatility can be extreme. Still, when it comes to Ripple, it’s important to avoid the nearer-term noise and think longer term.

Fisker Is Picking Up Speed, But It Will Have a Long Journey Ahead

Fisker stock has done exceedingly well since its IPO, but it is still a speculative name at best at this point.

GLSI Stock: Why Greenwich LifeSciences Is Up 2,000% Today

GLSI stock is soaring Wednesday after Greenwich LifeSciences shared promising results from its breast cancer immunothrapy.

Cloudflare Won’t Move Much Higher Until the Company Sees Profits

Cloudflare still has no profits in Its outlook leaving the stock stranded. Cloudflare stock won’t have a chance at moving much higher until the company can get profitable.

4 EV Stocks That Could Be the Next Tesla

Four electric vehicle (EV) stocks that can be value creators in the next decade. EV companies positioned to benefit from industry tailwinds.

High Valuation, Tough Competition Make Teladoc Stock Unattractive

At this point, TDOC stock looks overvalued, given the company's medium-term growth outlook.

Barron’s Says Ford Stock Can Double. Here’s Why That Won’t Happen

Barron's is excited about Ford stock because of the company's EV plans. But competition risks should dampen some of that enthusiasm.

DoorDash Stock IPO: The Good, The Bad And The Ugly

The DoorDash stock IPO on Wednesday gives investors a chance to buy a fast-growing "work-from-home" company. But why are investors balking?

ABCL Stock IPO: When Does AbCellera Go Public? What Is the AbCellera IPO Price Range?

AbCellera is continuing forward with its IPO plans and has provided new details in a filing with the SEC that investors will want to know.

C3.ai IPO: 16 Things for Potential AI Stock Investors to Know

C3.ai (AI) is moving forward with its IPO that launched today after bumping up the price of its stock above its previous range.

It’s Time to Be Cautious With General Electric Stock — Again

GE stock has soared on turnaround hopes — and there is good news. But back above $10, investors may be ignoring entrenched problems.